Sepax 2 versus other

processing methods
100%
Up to
% Total Nucleated Cell

80%
99.46%*
82%
Recovery Rate

60%
63%
40%

20%

0%
Automated Manual Manual
Closed System: Closed System: Open System:
Sepax 2 Triple Bag Tubes
*Conditions apply
The first private cord blood bank in Singapore that offers the
Sepax 2 automated processing technology, this Swiss-made
and U.S. FDA-cleared device can recover as high as 99.46%1 of
Total Nucleated Cells (TNC) from cord blood; up to 57%2 cell count
higher than other processing methods. It is also a functionally
closed processing system which ensures the sterility of the cord
blood by eliminating exposure to air contaminants.

Features of Sepax 2 and what it means to You, as a Parent

Features Benefits to YOU
Swiss Quality We process your babys cord blood with
Swiss-made patented automated cord blood processing system high Swiss precision, reliable, state-of-
the-art technology
Advanced technology with new protocols

Fully Automated The yield from cord blood processing

Requires no external centrifuge or operator intervention during processing is consistent, with reproducible high
results (that is, cell recoveries).
Controlled, smooth and precise separation by an advanced optical sensor

Cell Recovery More cells are recovered / harvested

Able to achieve as high as 99.46% Total Nucleated Cells (TNC) recovery rate
1 from your babys cord blood for future
treatment (if needed), allowing better
chance of a successful transplant

Safety Processing of your babys cord blood

Closed processing system unit is safe and highly sterile, leaving
zero opportunity for error
Each processing step is fully monitored and traceable throughout the procedure.
Prevents any sample mix-up and
Possesses a troubleshooting system. Even in cases of power failure, all cord
eliminates any possible cross-
blood units can be reprocessed without having errors
contamination of your babys precious
The only cord blood processing technology that processes one cord blood unit at cord blood unit
a time.
Conducts automated kit test before the start of procedure and pressure test to
check for any leakage.
It optimizes the sedimentation parameter for each cord blood unit.

Regulatory Approvals Meets international health, safety and

Cleared by U.S. FDA, approved by European Union (evidenced by CE Mark), and environmental requirements to ensure
Japan MHLW (Ministry of Health and Labor Welfare) consumer safety
Complies with the highest quality standards such as AABB & FACT-Netcord3

Statistics/Evidence Proven technology, equipment and

An advanced cord blood processing technology with proven transplant track consumables that are used by industry
record leader the true validation on the
quality of the Sepax automated
Worlds most tested and proven automated system
DCR No. 1935 Version C, July 2013, Sepax A4 Flyer

processing technology
Over 1 million cord blood units3 have been processed by the Sepax System in
over 50 countries, this is almost half of the worldwide processing procedures for
cord blood inventory
Trusted by majority of the worlds leading public and private cord blood banks
The Sepax system has been chosen by over 75% of the Netcord organizations
that group the leading public cord blood banks around the world.

First Bank Our investment in advanced technology

Cordlife is the first private cord blood bank in Singapore to offer automated cord now and in the future means you and
blood processing with Sepax 2. your family will benefit from any future
technology upgrade for the long-term
storage of your babys stem cells

References
1. Cordlife umbilical cord blood processing data as at 30 Apr 2013
2. Valeri et al., Transfusion 1996;36:303-8
3. Biosafe, manufacturer of Sepax (figures accurate as of 31 March 2013)